Healthcare and life science R&D is witnessing a paradigm shift due to advances in semiconductor device processing. The demand for quick and accurate diagnostics as well as the ever-increasing requirements of speed and efficiency in biomedical research is driving the need for smaller, faster and more accurate semiconductor devices. Growing applications of such devices in these markets are in turn enabling novel understanding, discovery and treatment of disease to make healthcare more affordable and efficient, both in and out of the clinic.
This webinar will focus on how Oxford Instruments fabrication solutions could enable you to build a wide variety of biomedical devices and overcome a variety of challenges including:
Dr Ravi Sundaram is the market manager for research and emerging technologies at Oxford Instruments Plasma Technology. He has been involved in materials research in several institutions such as EPFL, Switzerland, Max Planck Institute Stuttgart, Germany, IBM T.J Watson Research Labs, NY and Cambridge University where he worked on several aspects of 1D and 2D materials-based research from synthesis, fundamental science to prototype applications in sensors, optoelectronics and electronics. He joined Oxford Instruments to lead and coordinate R&D efforts towards 2D materials products. Currently, he is responsible for scoping out and developing a strategy for emerging technology markets such as 2Dmaterials, biomedical devices, integrated photonics, Quantum Technologies among others.